Penetrium Bioscience Inc. (KOSDAQ:187660)
12,510
-750 (-5.66%)
At close: Apr 28, 2026
Penetrium Bioscience Revenue
In the year 2024, Penetrium Bioscience had annual revenue of 9.74B KRW, down -29.33%.
Revenue
9.74B
Revenue Growth
-29.33%
P/S Ratio
70.30
Revenue / Employee
60.91M
Employees
160
Market Cap
685.09B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DreamCIS | 66.63B |
| HLB bioStep | 74.05B |
| P&K Skin Research Center | 22.78B |
| WOOJUNG BIO | 37.59B |
| DT&CRO CO. | 47.75B |
| C&R Research | 64.98B |
| SLS BIO | 3.98B |
| BioInfra | 23.15B |